A wide spectrum of neurological manifestations in pediatrics patients with the COVID-19 infection: a case series

Neurological symptoms in COVID-19 patients can also be found in the pediatric population, but they are usually described as mild symptoms. Herein, we described a case series of four pediatric patients with severe and highly heterogeneous central and peripheral nervous system manifestations. The obje...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurovirology 2021-10, Vol.27 (5), p.782-786
Hauptverfasser: Krueger, Mariana Braatz, Montenegro, Raquel Carvalho, de Araújo Coimbra, Pablo Picasso, de Queiroz Lemos, Luanna, Fiorenza, Regiane Martins, da Silva Fernandes, Carla Jéssica, Pessoa, Mariana Santos Leite, Rodrigues, Cleonísio Leite, da Cruz, Camilla Gomes, de Araújo Verdiano, Verlene, de Carvalho Araújo, Fernanda Montenegro, Braga-Neto, Pedro, Sobreira-Neto, Manoel Alves
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Neurological symptoms in COVID-19 patients can also be found in the pediatric population, but they are usually described as mild symptoms. Herein, we described a case series of four pediatric patients with severe and highly heterogeneous central and peripheral nervous system manifestations. The objective was to report neurological manifestations of COVID-19 in children and adolescents. The design is case series. The participants are four children and adolescents with confirmed COVID-19. The main outcome and measures are as follows: Clinical data were gathered from electronic medical records, and data of all neurologic symptoms were checked by a trained neurologist. We reported four pediatric patients with COVID-19 and different neurologic symptoms. Case 1 was a 16-year-old girl with a sensory and motor polyradiculopathy with RT-qPCR for COVID-19 and dengue both detected in CSF that improved after appropriate treatment. Case 2 was a 15-year-old boy with Guillain–Barre syndrome and had good response after using human immunoglobulin. Case 3 was a 5-year-old girl with acute intracranial hypertension that improved after going through lumbar puncture and using acetazolamide. Case 4 was a 2-month-old male infant with focal epileptic seizures that recovered after antiepileptic treatment. We highlight the need to consider different neurologic manifestations as part of the COVID-19 clinical spectrum.
ISSN:1355-0284
1538-2443
DOI:10.1007/s13365-021-01004-9